BioNTech is a biotechnology company based in Germany that focuses on developing and manufacturing innovative immunotherapies for the treatment of cancer and other serious diseases. Founded in 2008, it is particularly well-known for its pioneering work in mRNA technology. The company gained global prominence for its role in developing one of the first COVID-19 vaccines in collaboration with Pfizer, which used messenger RNA (mRNA) technology to induce an immune response against the SARS-CoV-2 virus. BioNTech’s research encompasses not only vaccines but also therapies targeting various types of cancers by harnessing the body’s immune system to fight disease.
BioNTech shifts focus from COVID-19 vaccines to pioneering cancer treatments using mRNA technology. Financial results for 2024 showed a decrease in earnings and revenue, yet surpassed market expectations. The company…